Plain-English translation of NCT07041450 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to create a faster, smarter way to screen people for new Alzheimer's disease treatments. This study combines two types of tests: a digital thinking test (similar to memory and puzzle games on a computer) and a simple blood test that measures proteins linked to Alzheimer's. By studying 500 people with memory concerns, the team hopes to build a tool that can quickly tell doctors who might be ready for these new treatments.
Current methods to diagnose Alzheimer's and determine who can receive new treatments take a long time—sometimes so long that patients miss the window when treatment could help most. This trial aims to speed up that process and make sure fewer people are left behind waiting for answers.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic for screening and complete a digital thinking test on a computer or tablet, answer questions about your health and memory, and have a blood draw. Your care partner will attend at least one visit to answer questions about your thinking and daily abilities. Some participants will also complete a paper version of a thinking test to help researchers compare digital and paper versions. The study will help create a faster pathway to see if you qualify for new Alzheimer's treatments.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Canada